12 Health Care Stocks Moving In Tuesday's After-Market Session

BenzingaApr 22 17:05 ET

Lixte Biotechnology Files to Sell 467,393 Shares of Common Stock for Holders

TipRanksApr 4 16:10 ET

LIXTE Launches New Study to Determine If Certain Pre-Cancerous Cells Found in an Aging Population Can Be Eliminated by LB-100

GlobeNewswireMar 31 08:30 ET

Lixte Biotechnology Provides Update on Progress With LB-100

TipRanksMar 27 08:47 ET

Express News | Lixte Biotechnology Provides Update on Progress With Proprietary Compound, Lb-100, to Treat Ovarian and Colorectal Cancer

ReutersMar 27 08:30 ET

LIXTE Biotechnology Provides Update On Progress With Proprietary Compound, LB-100, to Treat Ovarian and Colorectal Cancer

GlobeNewswireMar 27 08:30 ET

10-K: FY2024 Annual Report

SECMar 24 08:31 ET · Announcements

Express News | Lixte Biotechnology Holdings Inc - Terminates Sales Agreement With Wallachbeth Capital

ReutersMar 11 08:33 ET

Express News | LIXTE Biotechnology Announced Pre-Clinical Data Published in BioXriv and International Journal of Pharmaceutics Confirming LB-100's Conversion to Active Form Endothall, an Effective Cancer Treatment in Combination With Immunotherapy; Potential...

BenzingaMar 10 08:39 ET

New Findings Show How LIXTE's Lead Clinical Compound, LB-100, Is Metabolized to Its Active Form

GlobeNewswireMar 10 08:30 ET

LIXTE Adds Northwestern University's Lurie Cancer Center as Second Site in Ongoing Clinical Trial for Ovarian Clear Cell Cancer

GlobeNewswireFeb 25 08:30 ET

Express News | Lixte Adds NorthWestern University’s Lurie Cancer Center as Second Site in Ongoing Clinical Trial for Ovarian Clear Cell Cancer

ReutersFeb 25 08:30 ET

Lixte Biotechnology Closes $1.1 Million Direct Offering

MT NewswiresFeb 13 11:02 ET

Express News | Lixte Biotechnology Announces $1.05 Million Registered Direct Offering Priced at-the-Market Under Nasdaq Rules

ReutersFeb 11 08:42 ET

LIXTE Biotechnology Announces $1.05 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

GlobeNewswireFeb 11 08:42 ET

Why Lattice Semiconductor Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket

BenzingaFeb 11 05:53 ET

LIXTE Biotechnology Holdings, Inc. Withdraws Registration Statement for Proposed Public Offering

Quiver QuantitativeFeb 10 17:10 ET

LIXTE Biotechnology Submits Request for Withdrawal of Form S-1 Registration Statement

GlobeNewswireFeb 10 17:00 ET

Express News | Lixte Biotechnology Submits Request for Withdrawal of Form S-1 Registration Statement

ReutersFeb 10 17:00 ET

Express News | Lixte Biotechnology Holdings - on Dec 23, Eric Forman Resigns as Vp and COO of Lixte Biotech Effective as of Dec 31

ReutersDec 27, 2024 16:09 ET